Florida Center For Allergy and Asthma Care Revenue and Competitors

Miami, FL USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Florida Center For Allergy and Asthma Care's estimated annual revenue is currently $32.1M per year.(i)
  • Florida Center For Allergy and Asthma Care's estimated revenue per employee is $270,000

Employee Data

  • Florida Center For Allergy and Asthma Care has 119 Employees.(i)
  • Florida Center For Allergy and Asthma Care grew their employee count by 4% last year.

Florida Center For Allergy and Asthma Care's People

NameTitleEmail/Phone
1
Director Business OperationsReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Office ManagerReveal Email/Phone
4
PhysicianReveal Email/Phone
5
IT TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.2M220%N/AN/A
#2
$7.3M34-13%N/AN/A
#3
$8.6M408%N/AN/A
#4
$18M749%N/AN/A
#5
$24M8911%N/AN/A
#6
$17.3M716%N/AN/A
#7
$16M6635%N/AN/A
#8
$0.3M2100%N/AN/A
#9
$52.6M1775%N/AN/A
#10
$8.4M39-17%N/AN/A
Add Company

What Is Florida Center For Allergy and Asthma Care?

Florida Center For Allergy & Asthma Care, established in 1974, is the largest allergy and asthma center serving South Florida with the help of expert board-certified physicians, all who have extensive experience treating adults and children alike. We offer our highly-specialized services in multiple offices throughout the tri-county area of Miami-Dade, Broward and Palm Beach. We concentrate in the testing and treatment of allergies, asthma and other immune system disorders that affect people of all ages. Among the most common allergies we treat are allergic skin diseases, food, drug and pet allergies. Safety Information For urgent care, please call 911 or proceed to the nearest hospital.

keywords:N/A

N/A

Total Funding

119

Number of Employees

$32.1M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$29.3M1195%N/A
#2
$32.1M1197%N/A
#3
$16.7M119138%$46M
#4
$17.3M119138%N/A
#5
$17.3M11929%N/A